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A B S T R A C T
Regulatory T cells (Tregs) are vital for maintaining a balanced immune response and their dysfunction is often
associated with auto-immune disorders. We have previously shown that antigen-loaded anionic liposomes
composed of phosphatidylcholine (PC) and phosphatidylglycerol (PG) and cholesterol can induce strong antigen-
specific Treg responses. We hypothesized that altering the rigidity of these liposomes while maintaining their
size and surface charge would affect their capability of inducing Treg responses. The rigidity of liposomes is
affected in part by the length and saturation of carbon chains of the phospholipids in the bilayer, and in part by
the presence of cholesterol. We used atomic force microscopy (AFM) to measure the rigidity of anionic OVA323-
containing liposomes composed of different types of PC and PG, with or without cholesterol, in a molar ratio of
4:1(:2) distearoyl (DS)PC:DSPG (Young's modulus (YM) 3611 ± 1271 kPa), DSPC:DSPG:CHOL
(1498 ± 531 kPa), DSPC:dipalmitoyl (DP)PG:CHOL (1208 ± 538), DPPC:DPPG:CHOL (1195 ± 348 kPa),
DSPC:dioleoyl (DO)PG:CHOL (825 ± 307 kPa), DOPC:DOPG:CHOL (911 ± 447 kPa), and DOPC:DOPG
(494 ± 365 kPa). Next, we assessed if rigidity affects the association of liposomes to bone marrow-derived
dendritic cells (BMDCs) in vitro. Aside from DOPC:DOPG liposomes, we observed a positive correlation between
liposomal rigidity and cellular association. Finally, we show that rigidity positively correlates with Treg re-
sponses in vitro in murine DCs and in vivo in mice. Our findings underline the suitability of AFM to measure
liposome rigidity and the importance of this parameter when designing liposomes as a vaccine delivery system.
1. Introduction
Regulatory T cells (Tregs) are important for the resolution of in-
flammation after infection, immune suppression, and immune home-
ostasis [1]. They do so by producing anti-inflammatory cytokines [2],
consuming pro-inflammatory interleukin 2 (IL-2) and interrupting
effector T cell metabolism [3]. A reduction in the number or the dys-
function of Tregs has been implicated in many diseases, including type
1 diabetes, rheumatoid arthritis, and multiple sclerosis [4]. Due to their
immunosuppressive capacity, inducing Tregs is an attractive approach
for immunotherapy in inflammatory and auto-immune diseases. Ap-
proaches to induce tolerance include oral administration of disease-
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specific antigens [5], as well as the use of tolerogenic nanoparticles
(reviewed by Kishimoto and Maldonado [6]). Many of these tolerogenic
nanoparticles co-encapsulate antigens with ligands to enhance toler-
ance or inhibit effector responses, such as CD22 [7] or rapamycin [8,9],
respectively. However, it is possible to use “bare” particles that exploit
natural tolerogenic processes, generally by targeting scavenger re-
ceptors [10]. When using such nanoparticles, their physicochemical
properties determine their efficiency to induce antigen-specific Treg
responses. For instance, cationic particles are superior to anionic par-
ticles when comparing the efficiency of their association to APCs, as
well as induction of pro-inflammatory responses [11], whereas we and
other groups have shown that anionic nanoparticles like PG-containing
liposomes are more efficient at inducing tolerance [12,13]. Besides the
surface charge, particle size has also been shown to affect liposome-APC
interactions and subsequent induction of antigen-specific Tregs. For
example, nano-sized particles are taken up more efficiently by APCs
than micron-sized particles, leading to stronger APC activation and
subsequent immune responses [14]. Finally, the rigidity of nano-
particles is another important parameter for the induction of T cell
responses [15,16], however, to our knowledge, it is unknown whether
Treg responses are similarly affected by this parameter. The rigidity of a
particle, expressed here as YM, describes the deformation of an entire
particle and is not the same as the intrinsic deformation property of the
material(s) that the particle is made of. Rigid particles were previously
shown to be more efficiently taken up by macrophages compared to soft
particles [17], and rigid liposomes were able to induce stronger DC
activation in vivo [18]. Furthermore, rigid liposomes led to higher levels
of antigen presentation on MHC-II in DCs [19]. Finally, increasing li-
posomal rigidity has been shown to result in increased humoral and
cellular immune responses [20–22].
Here, we aimed to study the relationship between liposomal rigidity
and induced antigen-specific Treg responses. Liposomal rigidity is re-
lated to, but not the same as, the rigidity of the lipid bilayer. Bilayer
rigidity is strongly dependent on the transition temperature (Tm) of the
constituent phospholipids. Below the Tm, phospholipid bilayers are in a
relatively rigid gel state, whereas above the Tm they are in a (much less
rigid) liquid disordered state [23]. Analytical techniques such as dif-
ferential scanning calorimetry (DSC) [24] are commonly used to de-
termine the average Tm of liposomal bilayers. However, these techni-
ques do not measure the absolute rigidity of bilayers, let alone of
liposomal particles. Moreover, bilayers containing substantial amounts
of cholesterol (CHOL) lack a clear Tm [25], making the use of these
analytical techniques less useful. In the present study, we employed
atomic force microscopy (AFM), as this technique allows for simulta-
neous imaging and rigidity measurement of individual liposomes,
whether or not they contain CHOL [26]. Here we present an AFM-based
method to measure the YM of a range of anionic liposomes, by im-
mobilizing them on (3-aminopropyl)triethoxysilane (APTES)-modified
silicon plates. Moreover, we show that liposomal rigidity is positively
correlated with Treg responses against a loaded antigen in vitro and in
vivo.
2. Materials and methods
2.1. Materials
The phospholipids 1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dio-
leoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-distearoyl-sn-glycero-3-
phosphoglycerol (DSPG), 1,2-dipalmitoyl-sn-glycero-3- phosphogly-
cerol (DPPG), 1,2-dioleoyl-sn-glycero-3- phosphoglycerol (DOPG), and
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rho-
damine B sulfonyl) (DPPE-Rho) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA). Cholesterol (CHOL), APTES, acetic acid,
N,N′-diisopropyl carbodiimide (DIC), and triisopropyl silane were
purchased from Sigma-Aldrich (Zwijndrecht, the Netherlands). The
ovalbumin-derived peptide OVA323 (ISQAVHAAHAEINEAGR) was
purchased from Invivogen (San Diego, California, USA). Tentagel R-
RAM resin was purchased from Rapp Polymere (Tübingen, Germany).
Amino acids were supplied by Novabiochem (Merck, Darmstadt,
Germany). Dimethylformamide (DMF), trifluoracetic acid (TFA), pi-
peridine, pyridine, and acetonitrile were purchased from Biosolve
(Valkenswaard, the Netherlands). Oxyma was supplied by Carl Roth
(Karlsruhe, Germany). DCM was purchased from Honeywell (Fisher,
Landsmeer, the Netherlands). Diethyl ether was acquired from VWR
(Amsterdam, the Netherlands). Polycarbonate track-etched membranes
with a pore size of 400 nm and 200 nm were obtained from Millipore
(Kent, UK).
For cell culture, Ca2+- and Mg2+-free phosphate-buffered saline
(PBS), Iscove's Modified Dulbecco's Medium (IMDM), Roswell Park
Memorial Institute Medium (RPMI 1640), L-glutamine, and penicillin/
streptomycin were purchased from Lonza (Basel, Switzerland). Fetal
calf serum (FCS) was purchased from PAA Laboratories (Ontario,
Canada). β-mercaptoethanol was purchased from Sigma-Aldrich
(Zwijndrecht, the Netherlands). Granulocyte-macrophage colony-sti-
mulating factor (GM-CSF) was purchased from PeptroTech (London,
UK).
The antibodies CD45.1-PE-Dazzle594 (A20), Thy1.2-PE-Cy7
(53–2.1), Gata-3-PE (16E10A23), T-bet-APC (4B10), IL-17A-AF488
(TC11-18H10.1), and CD11c-PerCP-Cy5.5 (N418) were purchased from
Biolegend (CA, USA). FOXP3-eFluor450 (FJK-16S), CD25-AF488
(PC61.5), Ki-67-FITC (SolA15), fixable viability dye-APC-eFluor780, IL-
10-PerCP-Cy5.5 (JES5-16E3), IFNγ-APC (XMG1.2), and FOXP3/tran-
scription factor staining kit were purchased from eBioscience
(Thermofisher Scientific, MA, USA). CD4-V500 (RM4–5) was purchased
from BD Biosciences (CA, USA).
2.2. Methods
2.2.1. Preparation of OVA323-AF488
The OVA323 peptide with the sequence ISQAVHAAHAEINEAGRGC
was synthesized using a Liberty Blue microwave-assisted peptide syn-
thesizer. Synthesis was performed on a 0.1 mmol scale with a low-
loading (0.18 mmol/g) Tentagel® R-RAM resin. Amino acid activation
was performed using DIC as the activator and oxyma as a base, and
Fmoc-deprotection was performed with 20% piperidine in DMF. The
resin was washed five times with DMF and five times with di-
chloromethane. To protect the N-terminal amine, the peptide was re-
acted with 5% v/v acetic acid anhydride and 6% pyridine v/v in DMF
for 1 h at room temperature. Subsequently, cleavage from the resin was
performed using a mixture of TFA:triisopropyl silane:water, 38/1/1 v/
v/v. The peptide was precipitated using ice-cold diethyl ether. The
precipitate was collected by centrifugation before resuspension in wa-
ter:acetonitrile 4/1 v/v, after which the acetonitrile was evaporated
and the remaining aqueous solution was lyophilized overnight.
Purification was performed by RP-HPLC on a Kinetic Evo C18 column
with a Shimadzu system comprising two LC-8A pumps and an SPD-
10AVP UV–Vis detector. The collected fractions were analyzed using
LC-MS and pure fractions were pooled, the organic solvent was eva-
porated and the peptide solution was lyophilized overnight. To obtain
fluorescently labeled OVA323, the peptide was incubated for 48 h at 4 °C
with AlexaFluor 488 C5 maleimide (ThermoFisher Scientific,
Landsmeer, Netherlands) at pH 7.4 (100 mM HEPES buffer). The pur-
ified fluorescent peptide was obtained by RP-HPLC and mass was
confirmed by LC-MS.
2.2.2. Liposome preparation
Liposomes were prepared using the thin film dehydration-rehydra-
tion method, as described previously [27]. Briefly, phospholipids with
or without CHOL (10 mg/mL, 1 mL) were dissolved in chloroform and
mixed in a 50 mL round-bottom flask at a molar ratio of 4:1(:2)
PC:PG(:CHOL). The chloroform was evaporated under vacuum in a
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rotary evaporator (Rotavapor R-210, Büchi, Switzerland) for 1 h at
40 °C. The resulting lipid film was rehydrated with 250 μg OVA323
dissolved in 1 mL Milli-Q water and homogenized using glass beads.
The liposome dispersion was snap-frozen in liquid nitrogen, followed by
freeze-drying overnight (Christ alpha 1–2 freeze-dryer, Osterode, Ger-
many). The freeze-dried lipid cake was slowly rehydrated using 10 mM
sodium phosphate buffer (PB), pH 7.4. Two volumes of 500 μL and one
volume of 1000 μL PB were successively added, with intervals of 30 min
between each addition. The mixture was vortexed well between each
hydration step, and the resulting dispersion was left to rehydrate for at
least 1 h. The multilamellar vesicles were sized by high-pressure ex-
trusion (LIPEX Extruder, Northern Lipids Inc., Canada) by passing the
dispersion four times through stacked 400-nm and 200-nm pore size
membranes (Whatman® NucleporeTM, GE Healthcare, Little Chalfont,
UK). The resulting liposomes were assumed to be unilamellar. Homo-
genization, rehydration, and extrusion were performed at a tempera-
ture above the Tm of the phospholipids. To separate non-encapsulated
OVA323 from the liposomes, liposomes were washed in a Vivaspin 2
centrifuge membrane concentrator (MWCO 300 kDa, Sartorius, Göt-
tingen, Germany) by centrifugation at 524 g and 4 °C. To prepare
fluorescently labeled liposomes, 0.1 mol% of PC was replaced with
DPPE-Rho. To prepare liposomes with fluorescently labeled OVA323,
10% of the OVA323 was replaced with OVA323-AF488. Liposomes were
stored at 4 °C and used for further experiments within 2 weeks.
2.2.3. Liposome characterization
The Z-average diameter and polydispersity index (PDI) of the lipo-
somes were measured by dynamic light scattering (DLS) using a NanoZS
Zetasizer (Malvern Ltd., Malvern, UK). The same instrument was used
to measure ζ-potential by laser Doppler electrophoresis. The liposomes
were diluted 100-fold in PB to a total volume of 1 mL for these mea-
surements. Particle concentration was measured using nanoparticle
tracking analysis (NTA), as described previously [28], for optimal AFM
measurements. Liposomes were diluted in PB to a particle concentra-
tion between 107 and 109 particles/mL based on the DLS attenuation.
NTA measurements were performed using a NanoSight LM20 (Nano-
Sight, Amesbury, UK). Capture time was 60 s, the camera shutter was
set to 1500 ms, and gain to 680. To determine the concentration of
loaded OVA323, the peptide was extracted from liposomes using a
modified Bligh-Dyer method, as described previously [29]. Briefly,
100 μL of aqueous liposomal dispersion or a known concentration of
free peptide as control was mixed with 250 μL methanol and 125 μL
chloroform and vortexed. Then, 250 μL of 0.1 M HCl and 125 μL
chloroform were added and the mixture was vortexed and subsequently
centrifuged for 5 min at 524 g to separate the two phases. The upper
phase was collected and analyzed by RP- UPLC. Sample injections were
10 μL and the column used was a 1.7 μm BEH C18 column
(2.1 × 50 mm, Waters ACQUITY UPLC, Waters, MA, USA). Column and
sample temperatures were 40 °C and 4 °C, respectively. The mobile
phases were Milli-Q water with 0.1% TFA (solvent A) and acetonitrile
with 0.1% TFA (solvent B). For separation, the mobile phases were
applied in a linear gradient from 5% to 95% solvent B over 5 min at a
flow rate of 0.370 mL/min. Peptides were detected by absorbance at
214 nm using an ACQUITY UPLC TUV detector (Waters ACQUITY
UPLC, Waters, MA, USA).
2.2.4. Preparation of APTES-modified silicon plates
To allow for imaging of anionic liposomes, (negatively charged)
silicon plates were modified with APTES, to obtain a positively charged
surface, as described previously [30]. Briefly, the plates were washed
with acetone and methanol and dried in a vacuum oven (Binder, Ger-
many) for 30 min at 50 °C. The plates were incubated in a solution of 3/
7 v/v H2O2/H2SO4 at 120 °C to remove any organic contaminants and
to hydroxylize the silicon surface. The plates were then washed with
water and dried for 30 min in a vacuum oven. The plates were in-
cubated overnight in 2% v/v APTES in toluene, washed thoroughly
with toluene to remove any excess APTES, and subsequently washed
with methanol, and dried in a vacuum oven at 175 °C. Lastly, a curing
step for the hydrolysis of residual ethoxy groups was performed at
120 °C for 30 min followed by incubation in Milli-Q water at 40 °C for
2 h after which the plates were washed with methanol and stored in a
vacuum oven at 175 °C until use. The smoothness of the APTES-mod-
ified plates was confirmed using AFM in QI mode. A sharp cantilever
(Oltespa, Opus, Bulgaria) with a nominal spring constant of 2 N/m, a
nominal resonance frequency of 70 kHz and a tip radius of< 7 nm was
used to image the surface of the plates. The sample tilt was corrected
using the JPK Data Processing software v6.1.79 flattening function.
Images were extracted using Gwyddion v2.50 and the heights of
structures on the plates were determined. The roughness of the plates
was expressed as root mean square (RMS) [31], and plates used had
RMS values between 0.6 and 3 nm, which was deemed to have minimal
interference and to favor adsorption of liposomes [32].
2.2.5. Sample preparation for AFM measurements
APTES-modified plates were attached to glass microscope slides
using Reprorubber® (Thin Pour Kit, Flexbar Machine Corporation,
USA). A small glass ring with a diameter of 15 mm and a height of 3 mm
was attached on the plate to form a small basin. Next, 200 μL of lipo-
somal formulation (particle concentrations of about 1012–1013 parti-
cles/mL, as measured by NTA) was applied to the plate and incubated
at room temperature for 5 min. The plate was gently washed with PB
without exposure of the plate to air to remove free liposomes.
2.2.6. Scanning electron microscopy (SEM) of cantilevers
The cantilever tip radius of the HSC-20 cantilever (Team Nanotec,
Germany) was assessed by SEM using an FEI Nova nanoSEM 200.
Imaging was performed in high vacuum mode at 15 kV and a spot of 4.0
at a tilt of 45°. Images were captured at 200,000-fold magnification and
the radius of the cantilever tip was determined using the SEM software.
2.2.7. AFM measurements
To image the liposomes a JPK Nanowizard 3 (JPK Instruments AG,
Berlin, Germany) was used. Measurements were performed at
25 ± 1 °C in QI mode. The AFM probe used was a Team Nanotec
(Germany) HSC-20 hemispherical cone-shaped tip cantilever with gold-
reflective coating and metal carbide coating on the tip side, with a
nominal spring constant of 0.2 N/m, a nominal resonance frequency of
15 kHz and a tip radius of 35 nm, as determined by SEM. The cantilever
was calibrated using contact-based calibration and thermal tuning. For
calibration, the setpoint was 0.1 V on approach with a dynamic base-
line. Imaging of the liposomes was performed with a z-length 200 nm
and a set point between 0.5 and 0.85 nN. The area of the image was
2 × 2 μm at a resolution of 128 × 128 pixels with a pixel rate of
20 msec/pixel. Scan line artifacts were removed, line fitting was ap-
plied to the images, and sample tilt was corrected. Liposomes with a
height below 40 nm were excluded from analysis to prevent inter-
ference from the substrate. Force vs. height curves were measured for
each pixel of the AFM image. After subtracting the cantilever deflection,
the force vs. tip-sample separation (or distance) curves were fitted using
the Hertz/Sneddon model [33] for a hemispherical cantilever tip ac-









where F is the force as measured by AFM, R is the tip radius as mea-
sured by SEM, E is the YM, ν is Poisson's ratio, set to 0.5 for soft ma-
terials such as liposomes [35], and δ is the indentation of the sample,
also measured by AFM. The YM was determined for the center of the
liposomes.
Raw data images and force vs. height curves were processed using
JPK Data Processing software v6.1.70. Data from the images were ex-
tracted using Gwyddion v2.50. Between 31 and 450 liposomes were
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analyzed per formulation (Fig. 1.A).
2.2.8. BMDC culture
Bone marrow was isolated from the tibias and femurs of wild-type
(WT) C57BL/6 mice. A single-cell suspension of bone marrow cells was
obtained by straining over a 70 μm cell strainer (Greiner Bio-One B.V.,
Alphen aan den Rijn, NL). Cells were cultured for 10 days in complete
IMDM (cIMDM) which contains IMDM supplemented with 2 mM L-
glutamine, 8% v/v FCS, 100 U/mL penicillin/streptomycin, and 50 μM
β-mercaptoethanol at 37 °C and 5% CO2 in 95-mm Petri dishes (Greiner
Bio-One B.V., Alphen aan den Rijn, NL) and 20 ng/mL GM-CSF. The
medium was refreshed every other day.
2.2.9. Liposome or antigen association to BMDCs
BMDCs were cultured as described above. After 10 days of culture,
BMDCs were plated in F-bottom 96-well plates (Greiner Bio-One B.V.,
Alphen aan den Rijn, Netherlands) at 50,000 cells/well. To measure
association (either by uptake or adsorption) of liposomes to BMDCs,
liposomes prepared with 0.1 mol% Rho-DPPE or controls (non-fluor-
escent liposomes or medium) were added at a concentration of 20 μg/
mL lipids in supplemented IMDM. To measure OVA323 association to
DCs, liposomes encapsulating fluorescently labeled OVA323 were added
to a concentration of 0.1 μg/mL OVA323. Cells were incubated for 4 h at
37 °C and 5% CO2. Subsequently, excess liposomes were removed by
washing the cells several times with cIMDM, and cells were incubated
overnight. Cells were stained with a fluorescent antibody against
CD11c-PerCP-Cy5.5 (N418) and fixable viability dye-APC-eFluor780
and subsequently analyzed by flow cytometry (CytoFLEX S, Beckman
Coulter, CA, USA). The presence of the fluorescent label in DCs in-
dicated the association of either liposomes or peptide by BMDCs. Data
were analyzed with FlowJo software V10 (Treestar, OR, USA).
2.2.10. In vitro Treg induction by liposome-pulsed BMDCs
BMDCs were cultured as described above, plated to 50,000 cell/well
in a 96-well F-bottom plate, and pulsed for 4 h with liposomes or
controls in cIMDM. Spleens from OT-II mice were strained through a
70 μm cell strainer to obtain a single-cell suspension. Erythrocytes were
lysed using ammonium-chloride‑potassium (ACK) lysis buffer (0.15 M
NH4Cl, 1 mM KHCO3, 0.1 mM Na2EDTA
pH 7.3). CD4+ T cells were isolated using a CD4+ T cell isolation kit
(Miltenyi Biotec B.V., Leiden, Netherlands) according to the manufac-
turer's protocol. After exposure, BMDCs were washed with cIMDM to
remove free liposomes, and 100,000 CD4+ T cells/well were added to
the BMDCs. Co-cultures were incubated for 72 h in RPMI 1640 medium
supplemented with 2 mM L-glutamine, 10% v/v FCS, 100 U/mL peni-
cillin/streptomycin, and 50 μM β-mercaptoethanol. Cells were stained
for Thy1.2-PE-Cy7, CD4-V500, viability-APC-eFluor780, FOXP3-
eFluor450, and Ki-67-FITC, and analyzed by flow cytometry (CytoFLEX
S, Beckman Coulter, CA, USA). Data were analyzed using FlowJo soft-
ware V10 (Treestar, OR, USA).
2.2.11. Animals
C57BL/6 and OT-II transgenic mice on a C57BL/6 background were
purchased from Jackson Laboratory (CA, USA), bred in-house under
standard laboratory conditions, and provided with food and water ad
libitum. All animal work was performed in compliance with the Dutch
government guidelines and the Directive 2010/63/EU of the European
Parliament. Experiments were approved by the Ethics Committee for
Animal Experiments of Leiden University.
2.2.12. Adoptive transfer
Eleven-week-old female C57BL/6 mice were randomized into 4
groups based on weight. On day 0, all mice received 500,000
CD45.1+CD4+ T cells splenocytes isolated from a female OT-II trans-
genic mouse via the tail vein. On day 1, mice were immunized in-
travenously (i.v.) with a single injection of DSPC:DSPG,
DSPC:DSPG:CHOL, DOPC:DOPG or DOPC:DOPG:CHOL liposomes con-
taining 1 nmol OVA323 in PBS, in a total volume of 200 μL via the tail
Fig. 1. AFM measurements of liposomes. (A) Schematic overview of the AFM method used to determine the rigidity of liposomes. Liposomes were immobilized on
APTES-modified silicon plates. The rigidity of the liposomes was measured using AFM in QI mode. AFM images were processed in JPK data processing software
v6.1.70. Scan line artifacts were removed and images were corrected for baseline tilt. YM data per pixel was extracted by fitting each force-separation curve with the
Hertz/Sneddon model resulting in a YM map. To remove the interference of the silicon substrate, a mask was created in Gwyddion 2.50, selecting a threshold of
40 nm with a slope of< 20%. Liposomes touching the edges of the image were not included in the analysis. This mask was applied to the YM map, and YM data was
extracted for each liposome. Only the center of each liposome was used to calculate the mean YM per formulation. Representative AFM images of DSPC:DPPG:CHOL
liposomes. (B) Rigidity, expressed as YM, of the different liposomes. Data shown is mean values± SD, n = 31–450. Significant differences as measured by one-way
ANOVA are displayed in Table S3.
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vein. On day nine, mice were sacrificed by cervical dislocation and
spleens were immediately removed. Spleens were processed as men-
tioned above and stained for CD4-V500, CD45.1-PE-Dazzle594, Thy1.2-
PE-Cy7, viability-APC-eFluor780, CD25-AF488, Gata-3-PE, T-bet-APC,
and FOXP3-eFluor450 and measured by flow cytometry (CytoFLEX S,
Beckman Coulter, CA, USA). To measure cytokine production, spleno-
cytes were stimulated ex vivo with OVA323 (10 μg/mL). After 1 h bre-
feldin A (3 μg/mL) was added and cells were incubated for a further 5 h.
Cells were subsequently stained for CD4-V500, CD45.1-PE-Dazzle594,
Thy1.2-PE-Cy7, viability-APC-eFluor780, IFNγ-APC, IL-17A-AF 488,
and IL-10-PerCP-Cy5.5, and analyzed by flow cytometry. Data were
analyzed using FlowJo software V10 (Treestar, OR, USA).
2.2.13. Statistical analysis
Results were analyzed using one-way or two-way ANOVA, followed
by Bonferroni's multiple comparisons test and was performed using
GraphPad Prism version 8.1.1 for Windows (GraphPad Software, CA,
USA).
3. Results
3.1. Preparation of liposomes
Tregs are vital for maintaining immune homeostasis and are an
attractive target for immunotherapy. We have previously demonstrated
that liposomes prepared with DSPC, DSPG and CHOL in a molar ratio of
4:1:2 and loaded with an initial OVA323 concentration of 250 μg/mL
induce strong antigen-specific Treg responses. In order to assess how
the rigidity of these liposomes affects the Treg responses, we altered the
rigidity of the liposomes by using phospholipids with different carbon
chain-lengths (e.g. DSPC, di-18:0 PC vs. DPPC, di-16:0 PC), unsaturation
in the lipid chain (e.g. DSPC, di-18:0 PC vs. DOPC, di-18:1 (Δ9-Cis) PC)
or exclusion of CHOL (Table S1). The resulting liposomes were between
138 and 177 nm in size (Table 1). Exclusion of CHOL slightly, but
significantly, reduced the size of the liposomes (p < .05). All for-
mulations were monodisperse, indicated by a PDI of about 0.1. As ex-
pected, because of the incorporation of an anionic PG phospholipid, all
liposomes had a negative ζ-potential. The loading efficiency (LE) of the
OVA323 was between 11.4 and 24.6%.
3.2. Effect of lipid composition on liposome rigidity
To study the effect of lipid composition on the rigidity of the lipo-
somes, we measured the YM of the anionic liposomes by AFM.
Liposomes were successfully immobilized on APTES-modified silicon
plates and were imaged in quantitative imaging (QI) mode (Fig. 1 and
Table S2). AFM confirmed the size and monodispersity measured by
dynamic light scattering and allowed extraction of force-separation
curves and determination of the YM of single liposomes (Fig. 1A). The
most rigid liposomes were DSPC:DSPG liposomes, while the least rigid
liposomes were DOPC:DOPG liposomes (Fig. 1B). This was expected,
since DSPC:DSPG bilayers are in a gel state, and DOPC:DOPG bilayers
are in a liquid disordered state at 25 °C (Table 1). For DSPC:DSPG
liposomes, the addition of CHOL significantly reduced the YM (from
3611 ± 1271 kPa to 1498 ± 530 kPa, p < .001), while this was
reversed for DOPC:DOPG liposomes (from 493 ± 365 kPa to
911 ± 447 kPa, p = .0153). Interestingly, we observed that replacing
a small amount of a high-Tm phospholipid with a lower-Tm phospho-
lipid has the same effect as replacing all phospholipids by a lower-Tm
one. For instance, both DSPC:DPPG:CHOL (YM = 1159 ± 525 kPa),
where DSPC has a higher Tm than DPPC, and DPPC:DPPG:CHOL lipo-
somes (YM = 1211 ± 399 kPa) were significantly less rigid than
DSPC:DSPG:CHOL liposomes (YM = 1498 ± 531 p < .005), while
not being significantly different from each other (p > .99). A similar
effect was observed for DSPC:DOPG:CHOL and DOPC:DOPG:CHOL li-
posomes. Finally, we found that the Tm values and the molar ratio of the
constituent lipids do not significantly correlate with the rigidity of the
liposomes (Fig. S1).
3.3. Effect of liposomal composition on liposome association to BMDCs and
Treg responses in vitro
Next, we assessed how the rigidity of liposomes affects the uptake
by APCs and the induction of Tregs by the APCs. To this end, we in-
corporated a fluorescently labeled phospholipid, Rho-DPPE, into the
lipid bilayer and exposed BMDCs for 4 h to these formulations (Fig. 2A).
For almost all formulations, we observed a positive trend between li-
posomal rigidity and association. Interestingly, the highest association
was observed for the least rigid, DOPC:DOPG liposomes. It should be
noted, however, that the DOPC:DOPG liposomes showed primarily
passive association, indicated by high cell association at 4 °C (Fig. 2B),
while all other liposomes showed negligible association at 4 °C (Fig.
S2). Furthermore, DOPC:DOPG liposomes did not appear to effectively
deliver their cargo
while the association of DSPC:DSPG liposomes led to a significant
7.5-fold increase in OVA323 association compared to free OVA323
(control), both DOPC:DOPG:CHOL and DOPC:DOPG liposomes did not
increase OVA323 association compared to the control (Fig. 2C).
To determine whether the liposomal composition affected Treg re-
sponses, BMDCs were pulsed with liposomes for 4 h, and subsequently
co-cultured with OT-II CD4+ T cells. After three days of incubation,
induced Tregs were identified using flow cytometry (Fig. 3A, B, and C).
Among all tested OVA323-containing liposomes, the DSPC:DSPG lipo-
somes induced the strongest Treg responses, with a 1.6-fold increase in
% FOXP3+ population in live CD4+Ki-67+ T cell population compared
to free OVA323. Also DSPC:DSPG, DSPC:DSPG:CHOL,
DSPC:DPPG:CHOL, and DPPC:DPPG:CHOL liposomes showed sig-
nificantly higher Treg responses compared to free OVA323. Further-
more, we observed a significant correlation between the liposomal ri-
gidity (determined by AFM) and Treg responses (Fig. 3D). Interestingly,
there was no clear relationship between the association of liposomes
with BMDCs and subsequent Treg responses (Fig. 3E).
3.4. Effect of liposomal composition on Treg response in vivo
Next, we aimed to assess whether liposome rigidity affects Treg
Table 1
Physicochemical characteristics of liposomal formulations.
Lipid composition (molar ratio) Z-average ± SD (nm) PDI ± SD ζ-potential± SD (mV) LE (%)a Phase state at room temperature
DSPC:DSPG:CHOL (4:1:2) 166.1 ± 8.5 0.09 ± 0.05 −48.0 ± 6.0 16.0 ± 8.5 Lo
DSPC:DPPG:CHOL (4:1:2) 177.3 ± 6.6 0.08 ± 0.03 −46.4 ± 9.5 15.8 ± 5.5 Lo
DPPC:DPPG:CHOL (4:1:2) 173.5 ± 10.6 0.08 ± 0.04 −46.2 ± 11.7 24.7 ± 10.2 Lo
DSPC:DOPG:CHOL (4:1:2) 168.1 ± 17.0 0.10 ± 0.05 −45.8 ± 4.9 13.9 ± 3.9 Lo
DOPC:DOPG:CHOL (4:1:2) 158.7 ± 14.7 0.12 ± 0.03 −43.4 ± 5.1 24.8 ± 12.8 Lo
DSPC:DSPG (4:1) 138.4 ± 13.2 0.10 ± 0.03 −39.7 ± 5.7 11.4 ± 6.2 Gel
DOPC:DOPG (4:1) 140.1 ± 4.9 0.13 ± 0.03 −44.9 ± 5.9 24.6 ± 12.9 Ld
a Percentage of OVA323 amount remaining in liposomes after purification compared to the initial amount. Lo = Liquid ordered, Ld = liquid disordered.
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induction in vivo. An adoptive transfer mouse model using ovalbumin-
specific OT-II T cells was used to study the induction of antigen-specific
Treg responses by the liposomes in vivo. We selected the highest rigidity
(DSPC:DSPG) and lowest rigidity liposomes (DOPC:DOPG) and their
CHOL-containing counterparts. Both DSPC:DSPG and
DSPC:DSPG:CHOL liposomes showed a significantly higher expansion
of antigen-specific CD4+ T cells than the formulations containing DOPC
and DOPG (DSPC:DSPG 7.3 ± 0.9%, DSPC:DSPG:CHOL 7.3 ± 2.6%,
DOPC:DOPG:CHOL 4.1 ± 0.3%, and DOPC:DOPG 4.1 ± 0.7%,
Fig. 4A, B, C, D, and E). Moreover, in line with the in vitro results, the
Fig. 2. Liposomal association (uptake and/or ad-
sorption) by BMDCs in vitro. (A) OVA323-containing
fluorescently labeled liposomes were incubated for
4 h with BMDCs at 37 °C. Liposomes were subse-
quently washed away and cells were incubated
overnight before being analyzed via flow cytometry.
% Association indicates the percentage of live
BMDCs that are positive for the fluorescent label in
the liposomes. (B) Association of OVA323-containing
fluorescently labeled DOPC:DOPG liposomes at 37 °C
vs. 4 °C. (C) Association of encapsulated OVA323 to
BMDCs. Fluorescently labeled OVA323 was en-
capsulated in liposomes and incubated for 4 h with
BMDCs at 37 °C. Liposomes were subsequently wa-
shed away and cells were incubated overnight before
being analyzed by flow cytometry. Association was
normalized to % of BMDCs positive for fluorescently
labeled OVA323 in the free OVA323 control. Graphs
show mean ± SD, (A) n = 3, (B) n = 9, (C) n = 6.
****p < .0001, compared to free OVA323 de-
termined by one-way ANOVA and Bonferroni's mul-
tiple comparisons test.
Fig. 3. Induction of Tregs by OVA323-loaded liposomes in vitro. BMDCs were pulsed for 4 h with liposomes or controls and subsequently co-cultured for 72 h with
CD4+ T cells isolated from OT-II splenocytes. Flow cytometry was used to measure FOXP3+Ki-67+CD4+ T cells. Representative flow cytometry plots of
FOXP3+CD4+ T cells in the live Ki-67+CD4+ T cell population of OT-II T cells cultured with (A) free OVA323 (0.1 μg/mL) and (B) OVA323-loaded DSPC:DSPG
liposomes (0.1 μg/mL OVA323). (C) Summary Treg data of all liposomal formulations tested. Results were normalized to % FOXP3+Ki-67+CD4+ T cells in the free
OVA323 control. The dashed line at Y = 1 represents the free OVA323 control. Graph shows mean ± SD, n = 4. Linear correlations (95% CI) between (D) YM and
Treg response ratio, and (E) % association and Treg response ratio. ****p < .0001, **p < .01. *p < .05, compared to free OVA323 determined by one-way ANOVA
and Bonferroni's multiple comparisons test.
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total percentage of antigen-specific Tregs within the CD4+ T cell po-
pulation was highest for DSPC:DSPG liposomes, and decreased with
decreasing liposome rigidity (Fig. 4F). We observed no differences in
Th1 and Th2 responses between liposomal formulations (Fig. S3).
Furthermore, there were no differences in the production of IFNγ, IL-10
and IL-17A by splenocytes between liposomal formulations upon res-
timulation with OVA323 for 6 h (Fig. 4G, H and I), although we did find
a significant increase in production of IL-10 in all groups comparing
antigen-specific CD4+ T cells to CD45.1−CD4+ T cells, suggesting li-
posomal vaccination induces functional Tregs.
4. Discussion
The induction of antigen-specific Tregs through vaccination is an
attractive approach for the treatment of autoimmune diseases. We and
others have previously shown that nanoparticles, such as liposomes,
can be used to induce these Tregs [10,13]. Generally, approaches to
optimize such nanoparticles are focused on studying the effect of par-
ticle size and surface charge, while another important parameter, ri-
gidity, is often overlooked [15]. This parameter is usually approximated
by the phase properties of the lipid bilayers by analytical techniques
such as DSC and Laurdan anisotropy. Besides the fact that these tech-
niques only provide information about the bilayer of liposomes and
thereby exclude other influencing factors, such as size, lamellarity,
antigen content, and formulation excipients, there are other issues as-
sociated with these techniques. For instance, many liposomal for-
mulations contain CHOL in the lipid bilayer, which compromises the
suitability of techniques such as DSC [25], Fourier-transform infrared
spectroscopy (FTIR) [36], and Laurdan anisotropy [37]. Furthermore,
compounds encapsulated in liposomes can also interfere with DSC
Fig. 4. Expansion of OVA323 -specific Tregs in spleens of mice 8 days after i.v. injection of OVA323-containing liposomes. Representative flow cytometry plots of
OVA323-specific CD45.1+CD4+ T cells in the spleen of a mouse injected with (A) DSPC:DSPG, (B) DSPC:DSPG:CHOL, (C) DOPC:DOPG:CHOL and (D) DOPC:DOPG
liposomes containing OVA323. (E) Percentage of CD45.1+ cells in the CD4+ T cell population. (F) % of CD25+FOXP3+CD45.1+ Tregs in the CD4+ T cell population.
Graphs show mean ± SD, n = 8. *p < .05, **p < .01, compared to free OVA323 determined by one-way ANOVA and Bonferroni's multiple comparisons test.
Intracellular (G) IFNγ, (H) IL-10, and (I) IL-17A staining in splenocytes restimulated with 10 μg/mL OVA323 peptide for 6 h. ****p < .0001 comparing
CD45.1+CD4+ T cells to CD45.1+CD4+ T cells. No significant differences found between liposomal formulations as measured by two way ANOVA with Bonferroni's
post-test.
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[38,39] and FTIR measurements [40]. Other analytical techniques such
as measuring the ability of particles to be extruded [41,42] are indirect
measurements of rigidity. Importantly, all of the aforementioned tech-
niques can only measure the average properties of a batch of particles.
In contrast, AFM is an excellent technique to accurately measure the
rigidity of individual particles and is not hindered by the presence of
other compounds, such as CHOL and antigen. To further confirm this,
studies should be performed to compare AFM to other techniques that
measure liposomal rigidity.
We observed that CHOL reduces DSPC:DSPG liposome rigidity, and
increases DOPC:DOPG liposome rigidity. The lipid bilayers of liposomes
can generally be classified into three physical states with increasing
rigidity: liquid disordered (bilayers composed of low-Tm phospholi-
pids), liquid ordered (bilayers composed of high- or low-Tm phospho-
lipids containing at least 20 mol% CHOL) and gel state (bilayers con-
taining high-Tm phospholipids). In the gel state, CHOL disrupts the tight
packing of the lipids, while in the liquid disordered state, CHOL occu-
pies space at the interfacial region near the membrane surface and re-
places the hydrated CH2 groups. As the acyl chains become dehydrated
and straighten out, the packing becomes tighter and rigidity is therefore
increased [43]. While bilayer state is not the same as liposomal rigidity,
it is most likely one of the most important parameters that influence the
rigidity of the liposomes. This is also in line with results from Takechi-
Haraya et al. who used AFM to study the effect of CHOL on liposome
rigidity [44].
From our study, it became clear that the introduction of lipid order
mismatch significantly affects the rigidity of the liposomes. Mixing of
lipids with different phase transitions in the absence of CHOL can lead
to the formation of lipid domains (e.g. rigid domains and fluid do-
mains), which could destabilize the bilayer packing, and thereby the
rigidity of the liposomes [23]. We observed a significant decrease in
rigidity of liposomes in the presence of a small amount of lower-Tm
lipid (e.g. DSPC:DSPG:CHOL vs. DSPC:DPPG:CHOL, Table S3), which
did not further decrease upon complete substitution (e.g.
DSPC:DPPG:CHOL vs. DPPC:DPPG:CHOL). This suggests that the Tm
values and the molar ratio of the constituent lipids are poor predictors
of the rigidity of the liposomes (Fig. S1).
Physicochemical properties of liposomes other than bilayer com-
position can also affect their rigidity. For example, smaller liposomes,
measured by AFM, are more rigid than larger liposomes [45]. This may
be due to the different curvature of liposomes of different sizes, leading
to more restricted molecular interactions between the lipids of smaller
liposomes [46]. The charge of liposomes can also affect rigidity
neutral DOPC liposomes measured by AFM were shown to be more
rigid than anionic DOPC:DOPG or cationic DOPC:DOTAP liposomes.
This was hypothesized to be due to electrostatic repulsions causing
structural destabilization of the lipid bilayer [47]. Due to technical
limitations, the AFM measurements were performed at 25 °C. Since
temperature affects the phase state of the lipid bilayers, it also influ-
ences the rigidity of liposomes. However, the phase states of the used
phospholipids are the same at 25 °C and 37 °C (Table S1), so the trends
in YM at this physiologically more relevant temperature should be very
similar to those observed at 25 °C. Furthermore, a recent study found no
difference in anionic liposome stiffness over the temperature range of
25–37 °C [48]. Finally, antigen content may affect liposomal rigidity. In
this study, we have generated liposomal formulations with similar size,
antigen loading, and ζ-potential to allow an in vitro and in vivo assess-
ment primarily based on liposome rigidity.
The liposomes we measured had a range of YM from about 500 kPa
to almost 4 MPa (Fig. 1B). For comparison, the YM of most mammalian
cells was measured to be between 0.02 and 400 kPa [49] and that of
cortical bone was reported to be about 20 GPa [50]. Moreover, we have
used our AFM method to measure other anionic particle type, PLGA
nanoparticles (Z-average diameter of 142.1 ± 1.1 nm, PDI of
0.073 ± 0.016, ζ-potential −49.7 ± 4.2 mV), which had a YM of
14.4 MPa ± 1.8 MPa. This illustrates that the range of rigidities of the
liposomes is relatively small. This is especially true for the CHOL-con-
taining liposomes, the rigidity of which ranged from about 800 kPa to
1500 kPa (Fig. 1B). This was expected since their bilayers are all in the
liquid disordered state. However, even such small differences in rigidity
could be measured using our AFM method, and we could measure
significant differences between formulations (Table S3), illustrating the
strength of this technique.
We have reported the SD of YM values of all liposomes measured
within a batch. The SD of YM was relatively high for each liposomal
formulation. The high SD was not due to a lack of precision of the AFM
measurements, as repeated measurements of the same liposomes
showed very low variation (the difference between two measurements
of the same DSPC:DSPG:CHOL:OVA323 liposomes was 2.8%, Table S4).
Rather, it illustrates the variation in YM of the liposomes within a
formulation, which is likely due to differences in size, lamellarity, and
possibly antigen loading among different individual liposomes within
the same batch. Variation in YM as measured in two different batches of
DSPC:DSPG:CHOL:OVA323 liposomes was also very low
(1467 ± 575 kPa vs. 1510 ± 514, Fig. S4).
Based on previous reports we expected that the rigidity of the li-
posomes would positively correlate with their uptake by APCs since it
requires less energy for a cell membrane to wrap around rigid particles
[51]. It is known that phospholipid saturation has a significant effect on
their fate in biological systems. For instance, dimethyldioctadecy-
lammonium:trehalose 6,6′-dibehenate (DDA:TDB) liposomes showed
higher retention at the site of injection and uptake by APCs in vivo
compared to more fluid (as measured by DSC) dimethyldioleoy-
lammonium (DODA):TDB liposomes [18]. Furthermore, CHOL content
negatively correlated with uptake by THP-1-derived macrophages [52].
In our study, almost all formulations show a positive trend between
liposomal rigidity and APC association. However, DOPC:DOPG lipo-
somes showed the highest association to BMDCs of all tested formula-
tions (Fig. 2A), which was not expected since these liposomes presented
the lowest rigidity (Fig. 1B). Their route of uptake could be different
from that of the more rigid formulations. For instance, pure DOPC li-
posomes (YM of 45 kPa as measured by AFM) were hypothesized to fuse
with cells [53]. The DOPC:DOPG liposomes showed high passive as-
sociation (Fig. 2B), and did not deliver their cargo to BMDCs (Fig. 2C),
explaining their inability to induce T cell responses (Fig. 3C). There is
evidence of an inverse relationship between liposomal rigidity and
membrane permeability, as measured by calcein leakage [37]. So, it
may be that the peptide had leaked out of the DOPC:DOPG and
DOPC:DOPG:CHOL liposomes prior to BMDC association. This hy-
pothesis is supported by our observation that a mixture of free OVA323
and empty DOPC:DOPG or DOPC:DOPG:CHOL liposomes showed the
same amount of OVA323 association as encapsulated peptide (data not
shown). Since we used fluorescently-labeled lipids and peptides, we
cannot exclude the influence of the fluorophore itself on the measured
association in BMDCs. However, since all formulations (aside from
DOPC:DOPG liposomes) show almost no association of fluorophore
when incubated at 4 °C (Fig. S2), the fluorophore itself likely has no
effect on association.
We observed a clear correlation between the rigidity of the lipo-
somes and the Treg responses they elicited in vitro and in vivo (Figs. 3D,
4F). While others have shown a link between increased rigidity and
MHC-II presentation [19], and enhanced humoral and cellular re-
sponses [54,55], we are the first to report the effects of rigidity on Treg
responses. This may have implications for the design of delivery sys-
tems aimed to enhance antigen-specific Treg responses.
In conclusion, we showed that liposomal rigidity as measured by our
optimized AFM method is an important parameter in eliciting antigen-
specific Treg responses in vitro and in vivo. Our findings may contribute
to a better understanding of the factors driving Treg responses.
Moreover, this paper may contribute to a rational design of liposomal as
well as other nanoparticulate vaccine formulations aiming to enhance
antigen-specific Treg responses for the treatment of autoimmune
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